DekaBank Deutsche Girozentrale
DCPH

DekaBank Deutsche Girozentrale’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,000
Closed -$759K – 1487
2024
Q2 		$759K Hold
50,000
– – ﹤0.01% 932
2024
Q1 		$755K Hold
50,000
– – ﹤0.01% 925
2023
Q4 		$818K Buy
+50,000
New +$638K ﹤0.01% 938
2021
Q3 		– Sell
-16,400
Closed -$591K – 1433
2021
Q2 		$591K Sell
16,400
-20,000
-55% -$774K ﹤0.01% 1036
2021
Q1 		$1.49M Hold
36,400
– – ﹤0.01% 778
2020
Q4 		$1.99M Sell
36,400
-1,800
-5% -$107K 0.01% 668
2020
Q3 		$1.86M Buy
+38,200
New +$1.87M 0.01% 605

DekaBank Deutsche Girozentrale's DCPH Position: Q3 2024 in Review

DekaBank Deutsche Girozentrale sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2024, closing a stake of 50,000 shares — an estimated $759K sold.

DekaBank Deutsche Girozentrale first reported a position in DCPH in Q3 2020 and held it in 7 quarters. The position peaked at $1.99M in Q4 2020. 0 funds tracked by Wall St. Rank hold DCPH as of Q3 2024.

  • DekaBank Deutsche Girozentrale reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 50,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2024, an estimated $759K.
  • DekaBank Deutsche Girozentrale first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • DekaBank Deutsche Girozentrale's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.99M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2024, filed 24 Oct 2024.